BioAtla, Inc. Logo

BioAtla, Inc.

Develops antibody-based therapeutics activated within the tumor microenvironment.

BCAB | US

Overview

Corporate Details

ISIN(s):
US09077B1044
LEI:
Country:
United States of America
Address:
11085 TORREYANA ROAD, 92121 SAN DIEGO

Description

BioAtla, Inc. is a clinical-stage biopharmaceutical company that develops novel antibody-based therapeutics for the treatment of solid tumor cancers. The company's core focus is its proprietary Conditionally Active Biologics™ (CAB) platform. This technology is engineered to create protein therapeutics, including monoclonal antibodies, that are activated specifically within the physiological conditions of the tumor microenvironment. The primary goal of this approach is to enhance the therapeutic index of its drugs, making them safer and more effective by concentrating their activity on cancerous cells while minimizing damage to healthy tissue.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all BioAtla, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioAtla, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioAtla, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Basilea Pharmaceutica AG Logo
Biopharmaceutical firm developing drugs for severe bacterial and fungal infections.
Switzerland
BSLN
BASKHANBIOPharma Inc. Logo
Offers pharmaceuticals, medical devices, and health products for pain management.
South Korea
354390
Bausch Health Companies Inc. Logo
Develops, manufactures, and markets pharmaceuticals, OTC products, and medical devices.
United States of America
BHC
Bausch & Lomb Corp Logo
Global eye health company offering vision care, pharmaceutical, and surgical products.
United States of America
BLCO
Bavarian Nordic Logo
Biotechnology company developing and commercializing vaccines for infectious diseases.
Denmark
BAVA
BAXTER INTERNATIONAL INC Logo
Provides essential products for renal care, hospital, and surgical settings.
United States of America
BAX
Bayer AG Logo
A global life science company with core competencies in healthcare and nutrition.
Germany
BAY
BBS-Bioactive Bone Substitutes Oyj Logo
Develops and manufactures bioactive medical implants for orthopedic surgery.
Finland
BONE
BCWORLDPHARM Co., Ltd. Logo
Pharmaceutical company specializing in the R&D and manufacturing of prescription drugs.
South Korea
200780
Beam Therapeutics Inc. Logo
Develops precision genetic medicines using proprietary base editing technology.
United States of America
BEAM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.